Statement
8 Jun 2026
Pharmaceutical industry’s response to the Ebola Bundibugyo virus disease outbreak
The latest Ebola Bundibugyo outbreak in Democratic Republic of Congo, Uganda, and neighbouring countries is deeply concerning. Pharmaceutical and biotech companies are working with global partners in a coordinated response. Accelerating the response As the scientific, humanitarian, and global health response accelerates to contain the outbreak, pharmaceutical companies remain central to these efforts. While no...
Read more
Position paper
5 Jun 2026
IFPMA Note for Guidance on educational and scientific events (2026 update)
Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.
Read more
Statement
29 May 2026
79th World Health Assembly: Constituency statement on the follow-up to the Political Declaration on non-communicable diseases
On 21 May 2026, the International Federation on Ageing delivered a joint constituency statement on the follow-up to the Political Declaration on non-communicable diseases (NCDs) at the 79th session of the World Health Assembly. We urge WHO and Member States to ensure that implementation of the Political Declaration on the prevention and control of NCDs...
Read more